Xcout Intel
Recordati
Recordati is a global pharmaceutical company that develops and commercializes medicines for both common and rare diseases. It serves patients across approximately 150 countries through its specialty, primary care, and rare diseases operations.
Subscribe to see Recordati’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Recordati at a glance
Recordati is a pharmaceuticals company headquartered in Italy. Xcout tracks 9 named people at Recordati, including Robert Koremans (Chief Executive Officer).
Recordati leadership
- Robert KoremansChief Executive Officer
- Mike McClellanChief Financial Officer
- Alessandra AbateGroup Chief People and Culture Officer
- Bibianne BonGroup Chief Legal Officer
- Milan ZdravkovicExecutive VP Research & Development and Chief Medical Officer
- Alberto MartinezExecutive VP Specialty & Primary Care Business Unit
3 more named people on record for Recordati, with roles, board committees and tenure — see the full roster →
Recordati competitors
A few of Recordati's closest competitors — see the full list of competitors and alternatives →
Grünenthal is a global pharmaceutical company that researches, develops, and commercializes innovative treatments and medicines with a primary focus on pain management and related diseases. Operating as a science-based business, the company serves patients worldwide by delivering therapies for conditions such as chronic pain, rare diseases, and neurobiological indications.
Ipsen is a global biopharmaceutical company that researches, develops, and commercializes innovative medicines. It primarily serves patients suffering from conditions in the fields of oncology, rare diseases, and neuroscience.
Alfasigma is a global pharmaceutical company founded over 75 years ago and headquartered in Italy, with main offices in Bologna and Milan. The company also has U.S. operations.
STADA is a pharmaceutical company that develops and manufactures consumer healthcare products, specialty pharmaceuticals, and generic medicines. The company serves patients and healthcare providers globally by offering affordable medications and specialized treatments for various chronic, severe, and rare conditions.
Chiesi Farmaceutici is a global biopharmaceutical group that researches, develops, and commercializes therapeutic solutions for patients. The company focuses primarily on respiratory health, rare diseases, and specialty care.
H. Lundbeck A/S is a global pharmaceutical company that specializes exclusively in the research, development, and commercialization of therapies for brain diseases. It provides treatments for various neurological and psychiatric conditions, such as migraine, Parkinson's disease, Alzheimer's disease, depression, and schizophrenia, serving patients worldwide.
Get Recordati's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Recordati in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access